← Browse by Condition
Medical Condition

coronary arterial disease cad

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for coronary arterial disease cad sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — coronary arterial disease cad Clinical Trials

How many clinical trials are currently recruiting for coronary arterial disease cad?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for coronary arterial disease cad, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary arterial disease cad?
coronary arterial disease cad research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary arterial disease cad clinical trial?
Eligibility criteria for coronary arterial disease cad trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
IRCCS Ospedale San Raffaele 1 trial
University of Florida 1 trial
Cryotherapeutics SA 1 trial
Boston Scientific Corporation 1 trial
BrosMed Medical Co., Ltd 1 trial

Recruiting Clinical Trials

NCT07013344
Recruiting
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Enrollment
800 pts
Location
Italy
Sponsor
IRCCS Ospedale San Raffaele
View Trial →
NCT07025148 Phase 4
Recruiting
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
Enrollment
40 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT06939374
Recruiting
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
Enrollment
30 pts
Location
Belgium, United King...
Sponsor
Cryotherapeutics SA
View Trial →
NCT06959524
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Enrollment
1,616 pts
Location
United States, Austr...
Sponsor
Boston Scientific Corporation
View Trial →
NCT06822712
Recruiting
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions
Enrollment
250 pts
Location
China
Sponsor
BrosMed Medical Co., Ltd
View Trial →
NCT07001007
Recruiting
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
Enrollment
1,600 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
View Trial →
NCT07093788
Recruiting
Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
Enrollment
78 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
NCT06775028
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
Enrollment
1,250 pts
Location
Bulgaria, Denmark, I...
Sponsor
Heart Care Foundation
View Trial →
NCT06864234 Phase 4
Recruiting
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Enrollment
46 pts
Location
Belgium
Sponsor
VZW Cardiovascular Research Ce...
View Trial →
NCT06880575
Recruiting
Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
Enrollment
10,139 pts
Location
China
Sponsor
Beijing Hospital
View Trial →

Related Conditions

heart failure (2) chronic coronary syndrome (1) chronic coronary total occlusion (1) stable chronic angina (1) nt pro bnp (1) percutaneous coronary intervention pci (1) plaque (1) vulnerable plaque (1) cryotherapy (1) cryotherapy effect (1) coronary balloon (1) atherosclerosis coronary artery with angina pectoris (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology